Compliance Radar
Who was sanctioned, and for what?
Fines, court rulings and incidents from Europe and North America: 718 cases from 32 jurisdictions, each with an official source and checked against that source before publication. Filter by country, area of law and sector. Click a chart to drill down one level.
Click a bar to drill down one level.
Where?
by regionAll jurisdictions
What for?
by topicWho?
by companyWhen?
per quarter, by date of decision| Period | Cases | Total |
|---|---|---|
| Q3 2023 | 0 | — |
| Q4 2023 | 0 | — |
| Q1 2024 | 0 | — |
| Q2 2024 | 0 | — |
| Q3 2024 | 0 | — |
| Q4 2024 | 0 | — |
| Q1 2025 | 1 | €4,722 |
| Q2 2025 | 0 | — |
| Q3 2025 | 1 | — |
| Q4 2025 | 1 | €128,557 |
| Q1 2026 | 0 | — |
| Q2 2026 | 0 | — |
| Q3 2026 | 0 | — |
3 cases
3 Dec 2025 Southern Health Solutions, Inc. (Next Medical / NextMed)NextMed: FTC settlement over allegations of hidden costs and review manipulation €128,557
According to the FTC, the telemedicine company advertised GLP-1 weight-loss programmes with monthly prices that did not include medication, laboratory costs and medical consultations, concealed the minimum term and cancellation fees, published fake testimonials from employees and relatives, and induced customers to delete negative reviews by offering vouchers or refunds. Under the final settlement order, the company and its management are paying 150,000 USD, which is earmarked for refunds.
"Buying off" negative reviews with vouchers is just as misleading as inventing positive ones.
Review manipulation and price disclosures
- Authority / court
- Federal Trade Commission (FTC)
- Area of law
- Consumer protection and online retail · Fake reviews
- Legal basis
- Section 5 FTC Act; Restore Online Shoppers' Confidence Act (ROSCA)
- Action
- Disgorgement of profits
- Status of proceedings
- final
- Sector
- Healthcare
- Liability of senior managers
- Founder Robert Epstein and CEO Frank Leonardo III are named in the press release as parties involved.
- Published
- 3 Dec 2025
Original amount 150,000 USD, converted at the ECB reference rate of 3 Dec 2025.
- FTC Takes Action Against Telemedicine Firm NextMed Press release of an authority
- FTC Approves Final Order against Telehealth Provider NextMed (03.12.2025) Press release of an authority
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
31 Jul 2025 BGH: no before-and-after images for nose and chin correction with hyaluronic acid Order
A practice for aesthetic treatments advertised hyaluronic acid filler injections for the nose and chin on its website and on Instagram using before-and-after images. In an action brought by a consumer advice centre (Verbraucherzentrale), the BGH upheld the injunction issued by the Higher Regional Court of Hamm (OLG Hamm): such procedures are deemed to be surgical cosmetic procedures, for which this kind of advertising is prohibited.
Instagram posts are also advertising – the strict limits of the law on advertising for medicinal products and treatments (Heilmittelwerberecht) apply to aesthetic procedures.
Social media advertising for healthcare services
- Authority / court
- Bundesgerichtshof (I. Zivilsenat), Az. I ZR 170/24
- Area of law
- Consumer protection and online retail · Misleading advertising and pricing
- Legal basis
- § 11 Abs. 1 Satz 3 Nr. 1, § 1 Abs. 1 Nr. 2 Buchst. c HWG; UKlaG
- Action
- Order
- Status of proceedings
- final
- Sector
- Healthcare
- Published
- 31 Jul 2025
Checked against the official source on 25 Sep 2026 · Direct link
Report an error
6 Feb 2025 Медицински център „Люлин Мед“ ООДMC Lyulin Med presented practice as branch of the Military Medical Academy – 9,236 leva €4,722
Following a tip-off from the Military Medical Academy (VMA), the Комисия за защита на конкуренцията (Bulgarian Commission for the Protection of Competition, KZK) found that the centre presented its gynaecological practice as a VMA branch with signs reading ‘МЦ „ЛЮЛИН МЕД“ АГ – ВМА ФИЛИАЛ’ and corresponding online information. For misleading conduct (Art. 31 ZZK – Bulgarian Protection of Competition Act) it imposed 0.4% of 2023 turnover, i.e. 9,236 leva. An appeal has been lodged against the decision.
Cooperation with renowned institutions must not be presented as affiliation on signage and in online profiles.
- Authority / court
- Комисия за защита на конкуренцията (КЗК, Bulgarische Wettbewerbskommission)
- Area of law
- Consumer protection and online retail · Misleading advertising and pricing
- Legal basis
- Art. 31 ZZK (Irreführung)
- Action
- Fine
- Status of proceedings
- under appeal
- Sector
- Healthcare
Original amount 9,236 BGN, converted at the ECB reference rate of 6 Feb 2025.
- КЗК Публичен електронен регистър – Производство (Решение № 131 от 06.02.2025; Volltext als PDF im Register) Official register or notice
Checked against the official source on 25 Sep 2026 · Direct link